RecruitingNot ApplicableNCT07033975
A Specialized Diet for Multiple Sclerosis
A Flavonoid-enriched Mediterranean Diet for Multiple Sclerosis
Sponsor
Jerome J. A. Hendriks
Enrollment
100 participants
Start Date
Apr 4, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
This study examines the impact of a Mediterranean diet on individuals with multiple sclerosis (MS). MS is a multifactorial disease in which environmental factors, such as nutrition, can influence disease progression. Therefore, this study aims to investigate whether a healthier dietary pattern, specifically a flavonoid-rich Mediterranean diet, can affect disease parameters.
Eligibility
Min Age: 30 YearsMax Age: 65 Years
Inclusion Criteria1
- Expanded Disability Status Scale (EDSS): 0-6
Exclusion Criteria1
- Diagnosed digestive pathology
Interventions
OTHERFlavonoid-enriched Mediterranean Diet
A set of dietary guidelines describing an adjusted Mediterranean diet focusing on the intake of flavonoid-rich products.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07033975
Related Trials
From Genetics to Transcriptomics to Unravel the Mechanisms Behind a Poor Outcome in Multiple Sclerosis
NCT048734921 location
Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
NCT074776392 locations
Upper Limb Nerve Cryoneurolysis is Non Inferior to the Usual Care and Has Therapeutic Add Value in Dealing With Shoulder Pain and Functional Problems Caused by Spasticity and Motor Impairment
NCT067824641 location
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
NCT0381634552 locations
Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis
NCT072253611 location